2024 Partners

Lead Partner

Xenostart

XenoSTART is a global nonclinical oncology contract research organisation focused on the development and utilisation of patient-derived xenograft models. Founded in 2007, XenoSTART was created in close collaboration with The START Center, an international cancer treatment and research organisation. This partnership provides the unique ability to generate clinically-relevant XenoSTART patient-derived xenograft (XPDX) models.

Our XPDX models are clinically annotated and include patient treatment history and outcome and are characterised through genomic profiling, histologic analysis, and in vivo drug sensitivity to relevant standards of care.

www.xenostart.com

Expertise Partner

Certis Oncology Solutions

Certis Oncology Solutions is a life science technology company committed to realizing the promise of precision oncology. Our product is “Oncology Intelligence™”— highly predictive therapeutic response data derived from advanced biological models of cancer. Our proprietary platform informs individual treatment decisions and accelerates the development of new cancer therapies. We partner with therapeutics developers to help close the problematic translation gap between preclinical studies and clinical trials. Through more clinically relevant, well-characterized and annotated models, advanced imaging technology and thoughtfully designed studies, Certis brings greater certainty to go/no-go development decisions.

www.certisoncology.com

Champions Oncology

ChemPartner

ChemPartner is a CRO provider with 20 years of experience supporting drug discovery and development from concept to IND, with a focus on oncology, immunology, and CNS disease. Our oncology team offers >2,000 biochemistry assays, >800 cancer cell lines for screening and functional assays, >300 CDX and >50 syngeneic models at both subcutaneous and orthotopic settings, as well as >500 PDX. Additionally, ChemPartner has a fully equipped suite of ex vivo capabilities, such as flow, MSD, and IHC

www.chempartner.com

Expertise Partner

Hosting Partner

Exhibition Partner

CURESPONSE

CURESPONSE has developed a cutting-edge ex-vivo platform that preserves the tumor microenvironment (TME), achieving 90% accuracy in simulating human responses to oncology drug candidates. Based on research from the Weizmann Institute, this innovative technology delivers precise, actionable insights to accelerate drug development and reduce costs. By collaborating with both start-ups and leading pharma companies, CURESPONSE optimizes R&D for a wide range of oncology projects, including chemotherapy, biologics, immuno-oncology, CAR-T, ADCs, and more.

www.curesponse.com

GemPharmatech

GemPharmatech Co. Ltd. is a leading company in China to provide high-quality animal model resources and services for biomedical community as well as pharmaceutical companies. Based on more than 16 years’ practice in laboratory animals of the former entity, GemPharmatech has the vision and is striving to become one of the best one-stop service center for production, distribution, and phenotyping of gene-modified mouse models for partners all across the world.

www.gempharmatech.us/en

Genoway

For the past 20 years, genOway has aimed to improve the predictability and reliability of preclinical data by designing models of high physiological relevancy to best meet researchers’ needs. With a catalog of humanized immune checkpoint mouse models, and mice featuring the human immune system, genOway possesses a broad set of tools to help decipher the mechanism of action as well as the efficacy and safety of drugs targeting the immune system. Additionally, genOway owns strong intellectual property rights, combining patents and licensing agreements, enabling the company to provide end users the necessary freedom to operate.

www.genoway.com

Exhibition Partner

Histologix

HistologiX is a GLP/GCP-compliant CRO specialising in a range of services in histology, immunohistochemistry, immunofluorescence, multiplex assay development, in situ hybridisation, and tissue cross-reactivity studies. We also offer advanced digital pathology services, including whole slide scanning and quantitative image analysis. We support clients at all stages of the drug development pipeline, from early target identification and selection to preclinical development and clinical trials, offering comprehensive support throughout the process.

www.histologix.com

Lide

LIDE is an award-winning oncology contract research organization with 12 years of delivering drug evaluation services to 200+ clients worldwide. We offer traditional preclinical CRO services like pharmacology, PK, and biomarker studies with 70+ CDX models and 2000 patient-derived xenograft (PDX) models. Our library covers 50+ cancer types and 200+ models harbor special naturally-occurred drug-resistant and/or genetic alterations. Ask us about our proprietary tools for in-vivo drug validation in 7-10 days.

www.lidebiotech.com

Reaction Biology

Our clients are seeking answers in their quest to discover effective treatments for patients. Finding these answers is our mission as a CRO. Our method is to accelerate the drug discovery process with the widest possible range of assays and services but also to maintain an integrated view of the journey to a lead drug candidate. We strive to provide excellent data, delivered in a timely, collaborative manner by outstanding scientists. Who are we? We’re your partner.

www.reactionbiology.com

Exhibition Partner

WuXi AppTec

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the pharmaceutical and healthcare industry around the world to advance discoveries and deliver groundbreaking treatments to patients.

WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, and cell and gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions.

https://www.wuxiapptec.com

Sponsor - Tumour Models London Summit (1)

4th - 5th December | London, UK

10 PASSES REMAINING
DRUG DEVELOPERS
ATTEND FREE

2024 Partners

Lead Partner

Expertise Partner

Expertise Partner

Expertise Partner

Expertise Partner

Hosting Partner

Exhibition Partner

Exhibition Partner

Exhibition Partner

Exhibition Partner

Exhibition Partner

VENUE

LOCATION

OUR CONTACT DETAILS

JOIN OUR TEAM

ABOUT US

EXPLORE OUR PRODUCTS

SEARCH

4th - 5th December | London, UK

10 PASSES REMAINING DRUG DEVELOPERS ATTEND FREE

2024 Partners

Lead Partner

Expertise Partner

Expertise Partner

Expertise Partner

Expertise Partner

Hosting Partner

Exhibition Partner

Exhibition Partner

Exhibition Partner

Exhibition Partner

Exhibition Partner

VENUE

LOCATION

OUR CONTACT DETAILS

JOIN OUR TEAM

ABOUT US

EXPLORE OUR PRODUCTS

SEARCH

10 PASSES REMAINING
DRUG DEVELOPERS
ATTEND FREE